Celemics, Inc. (KOSDAQ:331920)
17,310
-190 (-1.09%)
At close: Apr 23, 2026
Celemics Market Cap
Celemics has a market cap or net worth of 130.63 billion as of April 24, 2026. Its market cap has increased by 448.89% in one year.
Market Cap
130.63B
Enterprise Value
125.09B
Revenue
5.77B
Ranking
n/a
PE Ratio
n/a
Stock Price
17,310.00
Market Cap Chart
Since August 21, 2020, Celemics's market cap has decreased from 200.32B to 130.63B, a decrease of -34.79%. That is a compound annual growth rate of -7.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 130.63B | 489.32% |
| Dec 30, 2025 | 22.17B | -17.10% |
| Dec 30, 2024 | 26.74B | -22.58% |
| Dec 28, 2023 | 34.53B | -27.07% |
| Dec 29, 2022 | 47.35B | -62.21% |
| Dec 30, 2021 | 125.32B | -42.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Livsmed | 1.49T |
| Biodyne | 366.69B |
| M.I.TECH Co.,Ltd | 221.69B |
| Synergy Innovation | 184.58B |
| BIOBIJOU | 128.18B |
| Corentec | 73.52B |
| DENTIS CO.,Ltd | 62.84B |
| Finemedix | 40.13B |